Abstract: The present invention relates to a novel process for the preparation of lifitegrast of Formula I. The present invention further provides a novel process for the purification of lifitegrast of Formula I.

Abstract: The present invention relates to a novel process for the preparation of lifitegrast of Formula I. The present invention further provides a novel process for the purification of lifitegrast of Formula I.

Abstract: The present invention relates to a novel, improved, commercially viable and industrially advantageous process for the preparation of Silodosin of Formula (I), its pharmaceutically acceptable salts or solvates thereof. The invention relates to the preparation of considerably pure Silodosin with high yield.

Abstract: The present invention provides novel process for the preparation of the ?1-adrenoceptor antagonists, Silodosin and its pharmaceutically acceptable salts indoline compounds, utilizing derivatives of Formula 1 and salts thereof.

Abstract: The present invention relates to novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I, and their salts wherein, R represents H or halogen. The present invention also relates to the use of novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I for preparation of Besifloxacin hydrochloride.

Abstract: The present invention provides novel process for the preparation of the ?1-adrenoceptor antagonists, Silodosin and its pharmaceutically acceptable salts indoline compounds, utilizing derivatives of Formula 1 and salts thereof.

Abstract: The present invention provides novel indoline compounds, derivatives of Formula 1 and salts thereof; which can be effectively used for the preparation of a 1-adrenoceptor antagonists, Silodosin and its pharmaceutically acceptable salts.

Abstract: The present invention relates to novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I, and their salts wherein, R represents H or halogen. The present invention also relates to the use of novel fluoroquinolone carboxylic acid compounds and derivatives of Formula-I for preparation of Besifloxacin hydrochloride.

Abstract: The present invention relates to a connector tongue element (1) for an electrical connector plug receptacle (4), the connector tongue element comprising: a flexible printed circuit (10) having an attachment portion (11); connector pins (12) attached and electrically connected to the flexible printed circuit at the attachment portion; and a first body (13) of polymeric material molded around at least a part of the attachment portion to form a connector base portion (14), the first body mechanically secures the attachment of the connector pins to the flexible printed circuit, wherein the connector pins extend from the connector base portion in a withdrawal direction along which an electrical connector plug is adapted to be withdrawn from the electrical connector plug receptacle; wherein the connector pins form a connector tongue portion (16) extending from the connector base portion in the withdrawal direction; and wherein the first body allow the connector pins to present connecting surfaces for connecting the

Abstract: The present invention relates to an improved process for the preparation of Linezolid of Formula-I comprising reacting compound of Formula-II with compound of Formula-III in presence of metal base wherein, said metal base is prepared in situ in a single lot. The invention also relates to an isolated acetamide impurity of Formula-IV produced in the process for preparation of Linezolid, its purification and its use as a reference marker.

Abstract: The present invention provides novel indoline compounds, derivatives of Formula 1 and salts thereof; which can be effectively used for the preparation of a1-adrenoceptor antagonists, Silodosin and its pharmaceutically acceptable salts.